BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Staging
7 results:

  • 1. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
    Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
    Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls.
    Hillenbrand A; Fassler J; Huber N; Xu P; Henne-Bruns D; Templin M; Schrezenmeier H; Wolf AM; Knippschild U
    BMC Cancer; 2012 Nov; 12():545. PubMed ID: 23173608
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Perioperative pai-1 values in surgically treated colorectal carcinoma patients under low molecular weight heparin thromboprophylaxis.
    Sturm D; Vazdar L; Bagatin D; Sakic K; Hrgovic Z
    Minerva Chir; 2012 Aug; 67(4):343-54. PubMed ID: 23022759
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.
    Herszényi L; Farinati F; Cardin R; István G; Molnár LD; Hritz I; De Paoli M; Plebani M; Tulassay Z
    BMC Cancer; 2008 Jul; 8():194. PubMed ID: 18616803
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (pai-1) expression in human colorectal carcinomas.
    Papadopoulou S; Scorilas A; Yotis J; Arnogianaki N; Plataniotis G; Agnanti N; Talieri M
    Tumour Biol; 2002; 23(3):170-8. PubMed ID: 12218297
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
    Baker EA; Bergin FG; Leaper DJ
    Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer].
    Herszényi L; Farinati F; Plebani M; István G; Sápi Z; Carraro P; De Paoli M; Naccarato R; Tulassay Z
    Orv Hetil; 1999 Aug; 140(33):1833-6. PubMed ID: 10489782
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.